SCHEMBL1034982

SCHEMBL1034982

Cc1cc(C(=O)CCc2sc3cc(C(F)(F)F)ccc3c2C)ccc1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.37
ESRRG P62508 1/20 0.36
ESR1 P03372 5/20 0.36
FFAR4 Q5NUL3 1/20 0.35
TBXAS1 P24557 1/20 0.34
DYRK1A Q13627 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
MMP1 P03956 1/20 0.33
AKT1 P31749 1/20 0.33
GPR52 Q9Y2T5 1/20 0.33
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33
AR P10275 1/20 0.33
ESR2 Q92731 1/20 0.33
HSD11B1 P28845 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SRC P12931 1/20 0.32
PRKACA P17612 1/20 0.32
PRKACG P22612 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032891 0.92 BCL2L1 (0.37) BCL2L1ESRRGESR1FFAR4TBXAS1
SCHEMBL1035053 0.88 BCL2L1 (0.35) BCL2L1ESRRGESR1FFAR4DYRK1A
SCHEMBL1034963 0.86 PPARD (0.44) FFAR4TBXAS1
SCHEMBL27829363 0.84 KCNK3 (0.41) CTNNB1WNT3AMEN1KMT2A
SCHEMBL1035838 0.83 PPARD (0.37)
SCHEMBL1032851 0.83 PPARD (0.47)
SCHEMBL1031757 0.83 PPARD (0.46)
SCHEMBL1035525 0.82 CYP1A2 (0.45) DYRK1ADYRK1BHSD11B1MEN1KMT2A
SCHEMBL1034041 0.81 ESR1 (0.43) ESR1FFAR4
SCHEMBL20292499 0.80 FBP1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD BCL2L1 765/4885ESRRG 111/4885ESR1 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.